Citadel Advisors »

Bridgebio Pharma shares owned by Citadel Advisors

Quarter-by-quarter ownership of Bridgebio Pharma (BBIO) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Bridgebio Pharma

Tip: Access up to 7 years of quarterly data

All positions including Bridgebio Pharma held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bridgebio Pharma by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $43M 1.1M 40.37
2023-09-30 $27M 1.0M 26.37
2023-06-30 $22M 1.3M 17.20
2023-03-31 $13M 804k 16.58
2022-12-31 $23M 3.0M 7.62
2022-06-30 $8.6M 943k 9.08
2022-03-31 $5.6M 552k 10.15
2021-12-31 $14M 818k 16.67
2021-09-30 $22M 478k 46.87
2021-06-30 $31M 515k 60.98
2021-03-31 $18M 291k 61.61
2020-12-31 $21M 297k 71.11
2020-09-30 $4.9M 129k 38.17
2020-06-30 $2.2M 68k 32.61
2020-03-31 $1.9M 66k 29.01
2019-06-30 $601k 22k 26.95